Bridgebio Oncology Therapeutics, Inc. (BBOT)

2.62 -0.08 (-2.96%) USD  |  NASDAQ  |  Oct 30, 16:00
2.64 +0.02 (+0.76%) After-Hours: 20:00
More

Bridgebio Oncology Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for BBOT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to . Start Trial.
Date Value

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Korsana Biosciences, Inc. Upgrade
IRulya Therapeutics, Inc. Upgrade
PepGen Inc. Upgrade
Q32 Bio, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade